- Previous Close
0.0000 - Open
0.0700 - Bid 0.0620 x --
- Ask --
- Day's Range
0.0700 - 0.0700 - 52 Week Range
0.0300 - 0.1100 - Volume
10,000 - Avg. Volume
3,363 - Market Cap (intraday)
36.53M - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Micro-X Limited designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa. The company offers carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for full medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; ARGUS for transforming stand-off imaging; Checkpoints, a modular passenger self-screening checkpoint for airports; and Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
www.micro-x.comRecent News: MCRXF
View MorePerformance Overview: MCRXF
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MCRXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MCRXF
View MoreValuation Measures
Market Cap
25.05M
Enterprise Value
26.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.35
Price/Book (mrq)
7.10
Enterprise Value/Revenue
3.97
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-76.33%
Return on Assets (ttm)
-51.45%
Return on Equity (ttm)
-134.23%
Revenue (ttm)
14.13M
Net Income Avi to Common (ttm)
-10.78M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.39M
Total Debt/Equity (mrq)
84.93%
Levered Free Cash Flow (ttm)
-8.83M